Article
DPP4-deficient congenic rats display blunted stress, improved fear extinction and increased central NPY.
Psychoneuroendocrinology - 1 Mar 2015
Canneva Fabio, Golub Yulia, Distler Joerg, Dobner Julia, Meyer Sandra, von Hörsten Stephan
Abstract excerpt
BACKGROUND: Inhibitors of dipeptidyl peptidase 4 (DPP4, CD26) are used for the treatment of type 2 diabetic patients and better glucose tolerance has been confirmed in functionally DPP4-deficient congenic rats (DPP4mut), along with immunological alterations and, interestingly, a stress-resilient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
